Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Pater

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|March 18, 2003
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophyQiujing Song, Albrecht G Schmidt, Harvey S Hahn, et al.
The Journal of Clinical Investigation|March 18, 2003
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and humanKobra Haghighi, Fotis Kolokathis, Luke Pater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2023
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapyJacob Hall, Kevin Lui, Xianming Tan, et al.
Pediatric Blood & Cancer|May 24, 2021
A safety and feasibility trial of <sup>131</sup> I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group studyBrian D Weiss, Gregory Yanik, Arlene Naranjo, et al.
Journal of Neuro-Oncology|October 9, 2020
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)Mariko DeWire, Christine Fuller, Trent R Hummel, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.
International Journal of Cancer|March 28, 2022
White paper: Oncofertility in pediatric patients with Wilms tumorM E Madeleine van der Perk, Nicholas G Cost, Annelies M E Bos, et al.
Transplantation and Cellular Therapy|November 14, 2025
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter StudyZahra Hudda, Aaron Webster, Eric Anderson, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|March 18, 2003
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophyQiujing Song, Albrecht G Schmidt, Harvey S Hahn, et al.
The Journal of Clinical Investigation|March 18, 2003
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and humanKobra Haghighi, Fotis Kolokathis, Luke Pater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2023
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapyJacob Hall, Kevin Lui, Xianming Tan, et al.
Pediatric Blood & Cancer|May 24, 2021
A safety and feasibility trial of <sup>131</sup> I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group studyBrian D Weiss, Gregory Yanik, Arlene Naranjo, et al.
Journal of Neuro-Oncology|October 9, 2020
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)Mariko DeWire, Christine Fuller, Trent R Hummel, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.
International Journal of Cancer|March 28, 2022
White paper: Oncofertility in pediatric patients with Wilms tumorM E Madeleine van der Perk, Nicholas G Cost, Annelies M E Bos, et al.
Transplantation and Cellular Therapy|November 14, 2025
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter StudyZahra Hudda, Aaron Webster, Eric Anderson, et al.
Pageof 3